Facts or Delusions: The Television Advertising of a Non-Prescription Drug Product

1980 ◽  
Vol 10 (4) ◽  
pp. 377-381 ◽  
Author(s):  
Donald E. Holst ◽  
Robert B. Sause
Keyword(s):  
Prescription Drug ◽  
Mode Of Action ◽  
Drug Product ◽  
Television Advertising ◽  
Health Educators ◽  
Television Advertisement ◽  
Topical Analgesic ◽  
Made In

A recent television advertisement for a topical analgesic cream is reviewed with an analysis and discussion of the claims made in the commercial concerning the mode of action and the effectiveness of the product. The claims, although based on fact, may be considered to be speculative. Advertisements of this type prove counterproductive to the educational efforts of health educators.

Identifying potential prescription drug product hopping

2021 ◽  
Vol 39 (4) ◽  
pp. 414-417
Author(s):  
Vrushab Gowda ◽  
Reed F. Beall ◽  
Aaron S. Kesselheim ◽  
Ameet Sarpatwari
Keyword(s):  
Prescription Drug ◽  
Drug Product

Direct-to-Consumer Prescription Drug Advertising

1999 ◽  
Vol 25 (1) ◽  
pp. 149-167
Author(s):  
Tamar V. Terzian
Keyword(s):  
Prescription Drug ◽  
Drug Administration ◽  
Food And Drug Administration ◽  
Pharmaceutical Products ◽  
Drug Advertising ◽  
Direct To Consumer ◽  
Prescription Drug Advertising ◽  
Adequate Provision ◽  
Package Labeling ◽  
Made In

The Food and Drug Administration (FDA) regulates the promotion of pharmaceutical products. The FDA's regulations issued under the Food, Drug and Cosmetic Act (FDCA) require that prescription drug broadcast advertisements include the following: (1) a major statement of the product's risks in at least the audio part of the advertisement; and (2) that an adequate provision for the dissemination of the approved package labeling be made “in connection with the broadcast presentation,” if the brief summary is not also part of the advertisement. Under the FDCA, the brief summary provides information concerning the major risks of the drug.

scholarly journals Impact of Television Advertisement on Undergraduate Students’ Purchase Decision on Indomie Noodles

2018 ◽  
pp. p27
Author(s):  
Ikechukwu Favour C ◽  
Agu Godswill Agu
Keyword(s):  
Undergraduate Students ◽  
Significant Influence ◽  
Television Advertising ◽  
Business Administration ◽  
Purchase Decision ◽  
Target Market ◽  
State University ◽  
Television Advertisement ◽  
Structured Questionnaire

This study surveys undergraduate students’ views on the effect of television advertisement on their purchase of indomie noodles. 392 respondents, drawn from the Business Administration unit of Abia State University were studied. The structured questionnaire was administered on the select respondents. The SPSS version 20 students t-test was used to test stated hypotheses. Finding disclosed that television advertising has a significant influence on students’ preference, patronage and repeat purchase of indomie noodles. The study recommends that Advertising messages should be clear, credible and precise so that the target market will not give different meanings to it and that noodles marketers should see television advertising as a long-term investment into the life of products and not be discouraged by the early, immediate low returns of advertisements.

OESTROGEN – ANTI-OESTROGEN INTERACTION: EFFECT OF U11100A, MRL-41 (CLOMIPHENE) AND U11555A ON OESTROGEN INDUCED UTERINE GLYCOGEN AND PROTEIN SYNTHESIS IN THE RAT DURING DELAYED IMPLANTATION

1969 ◽  
Vol 62 (3) ◽  
pp. 489-497 ◽  
Author(s):  
Suresh Mohla ◽  
M. R. N. Prasad
Keyword(s):  
Protein Synthesis ◽  
Comparative Study ◽  
Interaction Effect ◽  
Mode Of Action ◽  
Biochemical Changes ◽  
Delayed Implantation ◽  
Receptor Sites ◽  
Made In

ABSTRACT A comparative study of three non-steroidal anti-oestrogens (a dihydronaphthalene, UlllOOA; a diphenylindene derivative, U-11555A and MRL-41 (clomiphene) was made in order to study their mode of action and their interaction with oestrogen induced biochemical changes in the uterus. Pretreatment with UlllOOA, clomiphene or U11555A effectively blocked the oestrogen induced increase in uterine glycogen and protein synthesis. However, all the three compounds tested were found to be uterotrophic; clomiphene also increased uterine glycogen while U11555A showed a transient oestrogenic action in increasing uterine protein. Clomiphene and U11100A have been shown to inhibit the uptake of oestrogen at the receptor sites. Our results may be interpreted as indicating that pretreatment with these compounds (U11100A, clomiphene or U11555A) blocked the uterine receptor sites in such a manner so as to render ineffective the action of oestrogen administered subsequently.

scholarly journals Bioavailability Study of Propranolol Patch

2020 ◽  
Vol 3 (2) ◽  
Author(s):  
Muh Ikhlas Arsul ◽  
Latifah Rahman ◽  
Agnes Lidjajah
Keyword(s):  
Active Ingredient ◽  
Drug Product ◽  
Intravenous Route ◽  
Eudragit Rs ◽  
First Pass Effect ◽  
First Pass ◽  
Site Of Action ◽  
Bioavailability Study ◽  
Pvp K30 ◽  
Made In

Bioavailability is a measure of the rate and amount of drug or active ingredient that is absorbed by a drug product and available at the site of action. By definition, the bioavailability of a drug when administered intravenously is 100%. However, when a drug is given by a different route of administration, its overall bioavailability will decrease (since the drug is not completely absorbed and metabolized first pass effect) or may vary from patient to patient. Bioavailability is very important in pharmacokinetics. One of them is that bioavailability needs to be taken when calculating the doses for administering a drug other than by intravenous route. The aim of this study was to describe the bioavailability of propranolol in patch preparations. Propranolol is made in patch formulations using menthol, PEG, and various combinations of PVP and Eudragit. PVP and Eudragit each dissolved in alcohol and then mixed until homogeneous. Propranolol was dissolved with a menthol solution and then mixed into a solution of PVP and Eudragit. Finally, PEG is added to the solution and stirred until homogeneous and then poured into the patch mold. The patches produced were then measured for each patch and bioavailability assay. The patch formula produced can be used transdermally, but of the three formulas, the F3 formula with a ratio of PVP K30 and Eudragit RS-100 3: 7 gives the best results with a tmax of 2 hours, Cmax 79.33 µg / ml and AUC 49.07 µg hours / ml.

The Function of the Brain of Octopus in Tactile Discrimination

1957 ◽  
Vol 34 (1) ◽  
pp. 131-142
Author(s):  
M. J. WELLS ◽  
J. WELLS
Keyword(s):  
Mode Of Action ◽  
Sensory System ◽  
Sensory Nerves ◽  
Proprioceptive Information ◽  
Tactile Discrimination ◽  
Nerve Impulses ◽  
The Difference ◽  
Scanning Mechanism ◽  
The Brain ◽  
Made In

The results of fifty-three experiments in which octopuses were trained to make tactile discriminations between the members of pairs of Perspex cylinders are reported. Grooves cut into these otherwise smooth cylinders varied in number and arrangement. The proportion of errors made in distinguishing such objects depends upon the difference between the proportions of groove on the objects concerned, and is not affected by the pattern or orientation of the grooves. It has thus been possible to measure the similarity to Octopus of the objects used and to predict the errors that will be made in any such discrimination. When these results are considered in the light of the known nervous arrangements in the arms, it is possible to present a hypothesis about the mode of action of the peripheral tactile sensory system and the function of the brain. It is necessary to suppose that the latter distinguishes frequencies of nerve impulses in the sensory nerves from the arms; it is not necessary to postulate any projection of the sensory field or scanning mechanism involving the use of proprioceptive information.

Sign in / Sign up

Export Citation Format

Share Document